Nina Devlin - Mylan


Last quote by Nina Devlin

In the decade that Mylan has supplied ARVs, we have never had any supply disruption due non-compliance at any site and, again, we do not anticipate any supply disruption at this
share this quote
Apr 11 2017
We can learn a lot about a person if we know what types of things he or she talks about or comments on the most frequently. There are numerous topics with which Nina Devlin is associated, including Mylan and Tricare. Most recently, Nina Devlin has been quoted saying: “Mylan received an information request from the FTC months ago as part of a preliminary investigation. Any suggestion that Mylan took any inappropriate or unlawful actions to prevent generic competition is without merit. We note that the epinephrine auto-injector market is and always has been competitive, with multiple products competing on the market since we acquired EpiPen Auto-Injector. Further, Teva has had patent licenses to launch their proposed generic alternative to EpiPen Auto-Injector since June 2015, pending FDA approval, years prior to patent expiry.” in the article Mylan faces federal antitrust investigatior in EpiPen business. An other article where Nina Devlin has been quoted is EpiPen price hikes add millions to Pentagon costs.
Automatically powered by Storyzy
Take our quote verification challenge and find out !

Quotes by Nina Devlin

This webpage has been created by a robot: errors and absent quotes cannot be totally avoided

Quote :

Mistake :

Comments :